A comparative study of the efficacy of simvastatin and gemfibrozil in combined hyperlipoproteinemia: prediction of response by baseline lipids, apo E genotype, lipoprotein(a) and insulin (Q73229430)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 March 1997

Language	Label	Description	Also known as
English	A comparative study of the efficacy of simvastatin and gemfibrozil in combined hyperlipoproteinemia: prediction of response by baseline lipids, apo E genotype, lipoprotein(a) and insulin	scientific article published on 01 March 1997

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9105566%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

A comparative study of the efficacy of simvastatin and gemfibrozil in combined hyperlipoproteinemia: prediction of response by baseline lipids, apo E genotype, lipoprotein(a) and insulin (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9105566%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

0 references

1 reference

based on heuristic

inferred from title

Peter M. Clifton

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9105566%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9105566%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

P Nestel

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9105566%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

L Simons

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9105566%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

P Barter

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9105566%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

D Colquhoun

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9105566%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

I Hamilton-Craig

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9105566%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

D Sullivan

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9105566%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 March 1997

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9105566%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Atherosclerosis

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9105566%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

129

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9105566%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9105566%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

231-239

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9105566%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906031-5

7 January 2021

Familial lipoprotein disorders in patients with premature coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906031-5

7 January 2021

Pravastatin effectively lowers LDL cholesterol in familial combined hyperlipidemia without changing LDL subclass pattern

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906031-5

7 January 2021

Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906031-5

7 January 2021

Fibrates and statins in the treatment of hyperlipidaemia: an appraisal of their efficacy and safety

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906031-5

7 January 2021

Genetic basis of lipoprotein disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906031-5

7 January 2021

The response to lovastatin treatment in patients with heterozygous familial hypercholesterolemia is modulated by apolipoprotein E polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906031-5

7 January 2021

Effect of apolipoprotein E polymorphism and XbaI polymorphism of apolipoprotein B on response to lovastatin treatment in familial and non-familial hypercholesterolaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906031-5

7 January 2021

Postprandial changes in apolipoprotein(a) concentration of triglyceride-rich lipoproteins can be reproduced by in vitro incubation: implications for underlying mechanism.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906031-5

7 January 2021

Ciprofibrate therapy normalises the atherogenic low-density lipoprotein subspecies profile in combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906031-5

7 January 2021

Changes in composition and distribution of LDL subspecies in hypertriglyceridemic and hypercholesterolemic patients during gemfibrozil therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906031-5

7 January 2021

Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906031-5

7 January 2021

Comparative efficacy and safety of micronized fenofibrate and simvastatin in patients with primary type IIa or IIb hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906031-5

7 January 2021

Effects of lovastatin therapy on very-low-density lipoprotein triglyceride metabolism in subjects with combined hyperlipidemia: evidence for reduced assembly and secretion of triglyceride-rich lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906031-5

7 January 2021

Simvastatin improves chylomicron remnant removal in familial combined hyperlipidemia without changing chylomicron conversion.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906031-5

7 January 2021

Effect of gemfibrozil and lovastatin on postprandial lipoprotein clearance in the hypoalphalipoproteinemia and hypertriglyceridemia syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906031-5

7 January 2021

Influence of lovastatin on concentrations and composition of lipoprotein subfractions

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906031-5

7 January 2021

A comparison between the effects of gemfibrozil and simvastatin on insulin sensitivity in patients with non-insulin-dependent diabetes mellitus and hyperlipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906031-5

7 January 2021

Identifiers

10.1016/S0021-9150(96)06031-5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9105566%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9105566%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73229430&oldid=1753400029"